Kewaunee Scientific (KEQU) Reports Q4 EPS of $0.23

Kewaunee Scientific (NASDAQ: KEQU) reported Q4 EPS of $0.23, versus $0.37 reported last year. Revenue for the quarter came in at $30.3 million, versus $27.1 million reported last year.

Sales from domestic operations for the quarter were $25,196,000, up 19.6% from sales of $21,072,000 in the same period of prior year. Sales benefited from a strong level of incoming orders. Sales from international operations were $5,086,000, down 14.9% from sales of $5,980,000 in the same period of the prior year, primarily due to the timing of customer required ship dates for orders in the backlog.

For earnings history and earnings-related data on Kewaunee Scientific (KEQU) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15